Florian Vogl

Director Técnico/Científico/I+D en IMMUTEP LIMITED .

Health Technology

Consumer Services

Cargos activos de Florian Vogl

Empresas	Cargo	Inicio	Fin
IMMUTEP LIMITED	Director Técnico/Científico/I+D	01/05/2023	-

Empresas	Cargo	Inicio	Fin
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.	Corporate Officer/Principal	-	-
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.	Director Técnico/Científico/I+D	-	-

Ludwig-Maximilians-Universität München

Doctorate Degree

Internacional

Operativa

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Doctorate Degree	1

Sectorial

Health Technology	4
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
IMMUTEP LIMITED	Health Technology

Empresas privadas	2
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.	Health Technology
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.	Health Technology

Empresas privadas

Health Technology